Concepedia

Age-specific prostate-specific antigen: A reassessment

Ruth Etzioni, Yu Shen, Jason C. Petteway, Michael K. Brawer

The Prostate · 1996 · 27 citations · 23 references

DOI

Abstract

Using a bound of 4.0 ng/ml for all ages appears to be more efficient in identifying men with cancer in a screening cohort, which translates into a greater expected survival benefit per cancer case.

References

23

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

Thomas A. Stamey, Norman Yang, Alan R. Hay et al. · New England Journal of Medicine · 1987 · 2.5K citations

, , +14

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

William J. Catàlona, Deborah S. Smith, Timothy L. Ratliff et al. · New England Journal of Medicine · 1991 · 2.4K citations

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

William J. Catàlona, John P. Richie, Frederick R. Ahmann et al. · The Journal of Urology · 1994 · 1.4K citations

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

Joseph E. Oesterling · JAMA · 1993 · 1.1K citations

, , +4

Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening

William J. Catalona · JAMA · 1993 · 1K citations